ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. Post author:admERY Post published:June 17, 2012 Post category:Newsroom You Might Also Like ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014 ERYTECH Appoints Allene M. Diaz to its Board of Directors September 5, 2016 ERYTECH announces enrollment of first patient in Phase II study of eryaspase in pancreatic cancer July 28, 2014
ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014
ERYTECH announces enrollment of first patient in Phase II study of eryaspase in pancreatic cancer July 28, 2014
